These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29880362)

  • 1. Living-Donor Liver Transplantation in Hepatitis C Virus Era: A Report of 500 Consecutive Cases in a Single Center.
    Wahab MA; Shehta A; Elshoubary M; Yassen AM; Elmorshedi M; Salah T; Sultan AM; Fathy O; Elsarraf WR; Shiha U; Zalata K; Elghawalby AN; Eldesoky M; Monier A; Said R; Elsabagh AM; Ali M; Kandeel A; Abdalla U; Aboelella M; Elsadany M; Abdel-Khalek EE; Marwan A; ElMorsi FM; Adly R
    Transplant Proc; 2018 Jun; 50(5):1396-1406. PubMed ID: 29880362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Mortality in Living Donor Liver Transplantation.
    Elkholy S; Mogawer S; Hosny A; El-Shazli M; Al-Jarhi UM; Abdel-Hamed S; Salah A; El-Garem N; Sholkamy A; El-Amir M; Abdel-Aziz MS; Mukhtar A; El-Sharawy A; Nabil A
    Transplant Proc; 2017; 49(6):1376-1382. PubMed ID: 28736010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Surgical Complications but Improved Overall Survival with Adult Living Donor Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis.
    Tang W; Qiu JG; Cai Y; Cheng L; Du CY
    Biomed Res Int; 2020; 2020():1320830. PubMed ID: 32908865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation.
    Terrault NA; Shiffman ML; Lok AS; Saab S; Tong L; Brown RS; Everson GT; Reddy KR; Fair JH; Kulik LM; Pruett TL; Seeff LB;
    Liver Transpl; 2007 Jan; 13(1):122-9. PubMed ID: 17192908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor versus deceased donor liver transplantation: a surgeon-matched comparison of recipient morbidity and outcomes.
    Reichman TW; Katchman H; Tanaka T; Greig PD; McGilvray ID; Cattral MS; Renner EL; Selzner M; Ghanekar A; Levy G; Grant DR
    Transpl Int; 2013 Aug; 26(8):780-7. PubMed ID: 23746118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation.
    Shiffman ML; Stravitz RT; Contos MJ; Mills AS; Sterling RK; Luketic VA; Sanyal AJ; Cotterell A; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Oct; 10(10):1248-55. PubMed ID: 15376308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of living donor liver transplantation for hepatitis C virus (HCV)-positive patients.
    Takada Y; Haga H; Ito T; Nabeshima M; Ogawa K; Kasahara M; Oike F; Ueda M; Egawa H; Tanaka K
    Transplantation; 2006 Feb; 81(3):350-4. PubMed ID: 16477219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The travails of setting up a living donor liver transplant program: Experience from Pakistan and lessons learned.
    Dar FS; Bhatti AB; Dogar AW; Zia H; Amin S; Rana A; Nazer R; Khan NA; Khan EU; Rajput MZ; Salih M; Shah NH
    Liver Transpl; 2015 Jul; 21(7):982-90. PubMed ID: 25891412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: a systematic review and meta-analysis.
    Wan P; Yu X; Xia Q
    Liver Transpl; 2014 Apr; 20(4):425-36. PubMed ID: 24478109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of early recipient mortality after living donor liver transplantation in a tertiary care center in Egypt.
    Nafea MA; Alsebaey A; Abd El Aal Sultan A; Goda MH; Salman A; Rashed HS; Soliman A; Elshenoufy M; Abdelrahman M
    Ann Saudi Med; 2019; 39(5):337-344. PubMed ID: 31580715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality.
    Pan ZY; Fan YC; Wang XQ; Chen LK; Zou QQ; Zhou T; Qiu BJ; Lu YF; Shen CH; Yu WF; Luo Y; Su DS
    World J Gastroenterol; 2020 Mar; 26(12):1352-1364. PubMed ID: 32256022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
    Humar A; Ganesh S; Jorgensen D; Tevar A; Ganoza A; Molinari M; Hughes C
    Ann Surg; 2019 Sep; 270(3):444-451. PubMed ID: 31305283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.
    Tanemura A; Mizuno S; Kato H; Murata Y; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
    Transplant Proc; 2016 May; 48(4):1025-31. PubMed ID: 27320548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
    Lei J; Yan L; Wang W
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation.
    Thuluvath PJ; Yoo HY
    Liver Transpl; 2004 Oct; 10(10):1263-8. PubMed ID: 15376301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC; Fung JY; Pang HH; Leung CK; Li HF; Sin SL; Ma KW; She BW; Dai JW; Chan AC; Cheung TT; Lo CM
    Hepatology; 2021 Jun; 73(6):2441-2454. PubMed ID: 33006772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.